Cardio Diagnostics Stock Quote CDIO - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.71

Bid

3.70

Ask

3.81

Volume

25,379

3.69 Day's Range 3.89

3.40 52 Week Range 53.10

Market Cap

6.451M

Previous Close

3.89

Open

3.89

Last Trade

3.73

Last Trade Time

Financial Volume

$ 95,731

VWAP

3.7721

Average Volume (3m)

713,759

Shares Outstanding

1,738,710

Dividend Yield

PE Ratio

-0.77

Earnings Per Share (EPS)

-4.82

Revenue

35k

Net Profit

-8.38M

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector

Blank Checks

Industry

In Vitro,in Vivo Diagnostics

Headquarters

Dover, Delaware, USA

Founded

2021

Cardio Diagnostics Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was $3.89. Over the last year, Cardio Diagnostics shares have traded in a share price range of $ 3.40 to $ 53.10.

Cardio Diagnostics currently has 1,738,710 shares outstanding. The market capitalization of Cardio Diagnostics is $6.76 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -0.77.

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced...

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) (“Cardio Diagnostics” or the “Company”), a pioneer in AI-powered precision cardiovascular...

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a pioneer in AI-powered precision cardiovascular medicine, today announced the continued...

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Cardio Diagnostics Holdings, Inc. (“Cardio” or the “Company”) (NASDAQ: CDIO), today announced a 1-for-30 reverse stock split of its common stock...

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced its participation in...

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven Precision Cardiovascular Medicine company, today announced that the Company has...

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and...

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc...

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.19	-4.87179487179	3.9	4.175	3.65	38237	3.95266316	CS
4	-0.49	-11.6666666667	4.2	5.22	3.65	57026	4.38251441	CS
12	-8.497	-69.6076021955	12.207	17.388	3.4	713759	9.24848103	CS
26	-28.69	-88.549382716	32.4	34.2	3.4	1515295	16.40520766	CS
52	-11.89	-76.2179487179	15.6	53.1	3.4	2496807	17.0635387	CS
156	-123.79	-97.0901960784	127.5	254.997	3.4	2849462	46.4210973	CS
260	-123.79	-97.0901960784	127.5	254.997	3.4	2849462	46.4210973	CS

CDIO - Frequently Asked Questions (FAQ)

What is the current Cardio Diagnostics share price?

The current share price of Cardio Diagnostics is $ 3.71

How many Cardio Diagnostics shares are in issue?

Cardio Diagnostics has 1,738,710 shares in issue

What is the market cap of Cardio Diagnostics?

The market capitalisation of Cardio Diagnostics is USD 6.76M

What is the 1 year trading range for Cardio Diagnostics share price?

Cardio Diagnostics has traded in the range of $ 3.40 to $ 53.10 during the past year

What is the PE ratio of Cardio Diagnostics?

The price to earnings ratio of Cardio Diagnostics is -0.77

What is the cash to sales ratio of Cardio Diagnostics?

The cash to sales ratio of Cardio Diagnostics is 184.58

What is the reporting currency for Cardio Diagnostics?

Cardio Diagnostics reports financial results in USD

What is the latest annual turnover for Cardio Diagnostics?

The latest annual turnover of Cardio Diagnostics is USD 35k

What is the latest annual profit for Cardio Diagnostics?

The latest annual profit of Cardio Diagnostics is USD -8.38M

What is the registered address of Cardio Diagnostics?

The registered address for Cardio Diagnostics is 8 THE GREEN, SUITE #12490, DOVER, DELAWARE, 19901

Which industry sector does Cardio Diagnostics operate in?

Cardio Diagnostics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NXTTNext Technology Holding Inc	$ 3.44 (158.65%)	13.84M
WHLRWheeler Real Estate Investment Trust Inc	$ 7.15 (109.06%)	52.35M
CTORCitius Oncology Inc	$ 2.63 (69.68%)	20.77M
LUCYInnovative Eyewear Inc	$ 3.52 (54.39%)	111.21M
LGCLLucas GC Ltd	$ 1.0407 (53.16%)	11.17M
NWGLNature Wood Group Ltd	$ 1.71 (-69.63%)	3.99M
ICUSeaStar Medical Holding Corporation	$ 0.351 (-64.05%)	21.9M
MBRXMoleculin Biotech Inc	$ 0.259999 (-55.40%)	16.84M
RGCRegencell Bioscience Holdings Ltd	$ 37.50 (-40.81%)	2.22M
CGTLCreative Global Technology Holdings Ltd	$ 1.4399 (-36.57%)	6.71M
HCTIHealthcare Triangle Inc	$ 0.0297 (12.08%)	583.72M
DFLIDragonfly Energy Holdings Corporation	$ 0.245 (12.39%)	334.37M
GNLNGreenlane Holdings Inc	$ 0.009 (-13.04%)	262.88M
NVDANVIDIA Corporation	$ 143.85 (-1.12%)	242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 12.359 (-0.09%)	193.97M